FMC vs RARE · rev $1.63B vs rev $350.0M
FMC Corporation (FMC) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported FMC revenue for 2026-06-30 was $1.63B. Net income was -$467.9M. FMC currently screens at market cap $1.50B.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
FMC currently screens at market cap $1.50B. RARE currently screens at market cap $2.79B.
Not investment advice. Open the FMC and RARE stock pages for the full models.
Not investment advice.